ジカウイルス治療の世界市場：2022年～2026年

世界のジカウイルス治療の市場規模は、2022年～2026年の間に49億7,000万米ドルの増加が見込まれ、予測期間中にCAGRで5.25％の成長が予測されています。

市場は、ジカウイルス感染の質的診断のための血清検査キットの利用可能性、感染症の高い発生率、ジカウイルス感染症と関連する併存疾患による疾病負担によって牽引されています。

当レポートでは、世界のジカウイルス治療市場について調査分析し、全体的な分析、市場規模と予測、動向、促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を提供しています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場のエコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模：2021年
• 市場の見通し：2021年～2026年の予測

第4章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• サプライヤーの交渉力
• 新興企業の脅威
• 代替品の脅威
• 競合企業の脅威
• 市況

第5章 市場セグメンテーション：製品別

• 市場セグメント
• 比較：製品別
• アセトアミノフェン - 市場規模と予測：2021年～2026年
• その他のNSAID - 市場規模と予測：2021年～2026年
• 市場機会：製品別

第6章 顧客情勢

• 顧客情勢の概要

第7章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米 - 市場規模と予測：2021年～2026年
• 欧州 - 市場規模と予測：2021年～2026年
• アジア - 市場規模と予測：2021年～2026年
• その他の地域（ROW） - 市場規模と予測：2021年～2026年
• 米国 - 市場規模と予測：2021年～2026年
• デンマーク - 市場規模と予測：2021年～2026年
• 中国 - 市場規模と予測：2021年～2026年
• カナダ - 市場規模と予測：2021年～2026年
• インド - 市場規模と予測：2021年～2026年
• 市場機会：地域情勢別

第8章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第9章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第10章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Aurobindo Pharma Ltd.
• Bharat Biotech Ltd.
• Emergent BioSolutions Inc.
• GeoVax Labs Inc.
• Granules India Ltd.
• IMV Inc.
• Johnson and Johnson
• Perrigo Co. Plc
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Co. Ltd.

第11章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Product - Market share 2021-2026 (%)
• Exhibits25: Data Table on Product - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Product
• Exhibits27: Data Table on Comparison by Product
• Exhibits28: Chart on Acetaminophen - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Acetaminophen - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Acetaminophen - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Acetaminophen - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Other NSAIDs - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Other NSAIDs - Year-over-year growth 2021-2026 (%)
• Exhibits36: Market opportunity by Product ($ million)
• Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits40: Chart on Geographic comparison
• Exhibits41: Data Table on Geographic comparison
• Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on Denmark - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
• Exhibits78: Market opportunity By Geographical Landscape ($ million)
• Exhibits79: Impact of drivers and challenges in 2021 and 2026
• Exhibits80: Overview on Criticality of inputs and Factors of differentiation
• Exhibits81: Overview on factors of disruption
• Exhibits82: Impact of key risks on business
• Exhibits83: Vendors covered
• Exhibits84: Matrix on vendor position and classification
• Exhibits85: Aurobindo Pharma Ltd. - Overview
• Exhibits86: Aurobindo Pharma Ltd. - Product / Service
• Exhibits87: Aurobindo Pharma Ltd. - Key offerings
• Exhibits88: Bharat Biotech Ltd. - Overview
• Exhibits89: Bharat Biotech Ltd. - Product / Service
• Exhibits90: Bharat Biotech Ltd. - Key news
• Exhibits91: Bharat Biotech Ltd. - Key offerings
• Exhibits92: Emergent BioSolutions Inc. - Overview
• Exhibits93: Emergent BioSolutions Inc. - Product / Service
• Exhibits94: Emergent BioSolutions Inc. - Key news
• Exhibits95: Emergent BioSolutions Inc. - Key offerings
• Exhibits96: GeoVax Labs Inc. - Overview
• Exhibits97: GeoVax Labs Inc. - Product / Service
• Exhibits98: GeoVax Labs Inc. - Key news
• Exhibits99: GeoVax Labs Inc. - Key offerings
• Exhibits100: Granules India Ltd. - Overview
• Exhibits101: Granules India Ltd. - Product / Service
• Exhibits102: Granules India Ltd. - Key news
• Exhibits103: Granules India Ltd. - Key offerings
• Exhibits104: IMV Inc. - Overview
• Exhibits105: IMV Inc. - Product / Service
• Exhibits106: IMV Inc. - Key news
• Exhibits107: IMV Inc. - Key offerings
• Exhibits108: Johnson and Johnson - Overview
• Exhibits109: Johnson and Johnson - Business segments
• Exhibits110: Johnson and Johnson - Key news
• Exhibits111: Johnson and Johnson - Key offerings
• Exhibits112: Johnson and Johnson - Segment focus
• Exhibits113: Perrigo Co. Plc - Overview
• Exhibits114: Perrigo Co. Plc - Business segments
• Exhibits115: Perrigo Co. Plc - Key offerings
• Exhibits116: Perrigo Co. Plc - Segment focus
• Exhibits117: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibits118: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibits119: Sun Pharmaceutical Industries Ltd. - Key offerings
• Exhibits120: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits121: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits122: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits123: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits124: Inclusions checklist
• Exhibits125: Exclusions checklist
• Exhibits126: Currency conversion rates for US$
• Exhibits127: Research methodology
• Exhibits128: Validation techniques employed for market sizing
• Exhibits129: Information sources
• Exhibits130: List of abbreviations

Technavio has been monitoring the zika virus therapeutics market and it is poised to grow by $ 4.97 billion during 2022-2026, accelerating at a CAGR of 5.25% during the forecast period. Our report on the zika virus therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the availability of serology kit for qualitative diagnosis of zika virus infection, high incidence rate of infection, and disease burden of zika virus infection and associated comorbidities.

The zika virus therapeutics market analysis includes the product segment and geographic landscape.

Technavio's zika virus therapeutics market is segmented as below:

By Product

• Acetaminophen
• Other NSAIDs

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing efforts by government and private organizations to facilitate vaccine development as one of the prime reasons driving the zika virus therapeutics market growth during the next few years. Also, classification of zika virus infection as a public health emergency and novel approach for vaccine development will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on zika virus therapeutics market covers the following areas:

• Zika virus therapeutics market sizing
• Zika virus therapeutics market forecast
• Zika virus therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading zika virus therapeutics market vendors that include Johnson and Johnson, Aurobindo Pharma Ltd., Granules India Ltd., Perrigo Co. Plc, Sun Pharmaceutical Industries Ltd., Bharat Biotech Ltd., Emergent BioSolutions Inc., Takeda Pharmaceutical Co. Ltd., GeoVax Labs Inc., IMV Inc., Inovio Pharmaceuticals Inc., Moderna Inc., Merck and Co. Inc., and Valneva SE. Also, the zika virus therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

• 5.1 Market segments
• Exhibit 24: Chart on Product - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
• 5.2 Comparison by Product
• Exhibit 26: Chart on Comparison by Product
• Exhibit 27: Data Table on Comparison by Product
• 5.3 Acetaminophen - Market size and forecast 2021-2026
• Exhibit 28: Chart on Acetaminophen - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Acetaminophen - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Acetaminophen - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Acetaminophen - Year-over-year growth 2021-2026 (%)
• 5.4 Other NSAIDs - Market size and forecast 2021-2026
• Exhibit 32: Chart on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Other NSAIDs - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Other NSAIDs - Year-over-year growth 2021-2026 (%)
• 5.5 Market opportunity by Product
• Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Denmark - Market size and forecast 2021-2026
• Exhibit 62: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Denmark - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
• 7.9 China - Market size and forecast 2021-2026
• Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.10 Canada - Market size and forecast 2021-2026
• Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.11 India - Market size and forecast 2021-2026
• Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 84: Matrix on vendor position and classification
• 10.3 Aurobindo Pharma Ltd.
• Exhibit 85: Aurobindo Pharma Ltd. - Overview
• Exhibit 86: Aurobindo Pharma Ltd. - Product / Service
• Exhibit 87: Aurobindo Pharma Ltd. - Key offerings
• 10.4 Bharat Biotech Ltd.
• Exhibit 88: Bharat Biotech Ltd. - Overview
• Exhibit 89: Bharat Biotech Ltd. - Product / Service
• Exhibit 90: Bharat Biotech Ltd. - Key news
• Exhibit 91: Bharat Biotech Ltd. - Key offerings
• 10.5 Emergent BioSolutions Inc.
• Exhibit 92: Emergent BioSolutions Inc. - Overview
• Exhibit 93: Emergent BioSolutions Inc. - Product / Service
• Exhibit 94: Emergent BioSolutions Inc. - Key news
• Exhibit 95: Emergent BioSolutions Inc. - Key offerings
• 10.6 GeoVax Labs Inc.
• Exhibit 96: GeoVax Labs Inc. - Overview
• Exhibit 97: GeoVax Labs Inc. - Product / Service
• Exhibit 98: GeoVax Labs Inc. - Key news
• Exhibit 99: GeoVax Labs Inc. - Key offerings
• 10.7 Granules India Ltd.
• Exhibit 100: Granules India Ltd. - Overview
• Exhibit 101: Granules India Ltd. - Product / Service
• Exhibit 102: Granules India Ltd. - Key news
• Exhibit 103: Granules India Ltd. - Key offerings
• 10.8 IMV Inc.
• Exhibit 104: IMV Inc. - Overview
• Exhibit 105: IMV Inc. - Product / Service
• Exhibit 106: IMV Inc. - Key news
• Exhibit 107: IMV Inc. - Key offerings
• 10.9 Johnson and Johnson
• Exhibit 108: Johnson and Johnson - Overview
• Exhibit 109: Johnson and Johnson - Business segments
• Exhibit 110: Johnson and Johnson - Key news
• Exhibit 111: Johnson and Johnson - Key offerings
• Exhibit 112: Johnson and Johnson - Segment focus
• 10.10 Perrigo Co. Plc
• Exhibit 113: Perrigo Co. Plc - Overview
• Exhibit 114: Perrigo Co. Plc - Business segments
• Exhibit 115: Perrigo Co. Plc - Key offerings
• Exhibit 116: Perrigo Co. Plc - Segment focus
• 10.11 Sun Pharmaceutical Industries Ltd.
• Exhibit 117: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 118: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 119: Sun Pharmaceutical Industries Ltd. - Key offerings
• 10.12 Takeda Pharmaceutical Co. Ltd.
• Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 123: Takeda Pharmaceutical Co. Ltd. - Key offerings

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 124: Inclusions checklist
• Exhibit 125: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 126: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 127: Research methodology
• Exhibit 128: Validation techniques employed for market sizing
• Exhibit 129: Information sources
• 11.5 List of abbreviations
• Exhibit 130: List of abbreviations